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Abstract
Background: The prevalence of abdominal obesity is increasing worldwide. Adults with abdominal obesity have
been reported to have increased risk of cardiometabolic disorders.
The aim of this study was to examine whether non-obese subjects (body mass index (BMI) < 25 kg/m2) with
abdominal obesity examined in the framework of the Swiss–Hungarian Cooperation Programme had increased
metabolic risk compared to participants without abdominal obesity.
Methods: A cross-sectional study was carried out in 5228 non-obese individuals. Data were collected between July
2012 and February 2016. Descriptive statistics, Pearson’s correlation analysis and multiple logistic regression models
were applied, odds ratios (OR) with 95% confidence interval (CI) being the outcomes.
Results: 607 (11.6%) out of the 5228 non-obese individuals had abdominal obesity. The correlation analysis
indicated that the correlation coefficients between BMI and waist circumference (WC) were 0.610 in males and
0.526 in females. In this subgroup, the prevalence of high systolic blood pressure, high fasting blood glucose, and
high total cholesterol and triglyceride levels were significantly higher. The logistic regression model based on these
data showed significantly higher risk for developing high systolic blood pressure (OR = 1.53; 95% CI = 1.20–1.94), low
HDL cholesterol (OR = 2.06; 95% CI = 1.09–3.89), and high trygliceride level (OR = 1.65; 95% CI = 1.27–2.16).
Conclusions: There was a very high, significant, positive correlation between WC and BMI. Abdominal obesity was
found to be strongly related to certain metabolic risk factors among non-obese subjects. Hence, measuring waist
circumference could be recommended as a simple and efficient tool for screening abdominal obesity and related
metabolic risk even in non-obese individuals.
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Background
Obesity is one of the major public health concerns of
our era: its prevalence has increased significantly in the
past decades both globally [1, 2] and in Hungary [3, 4].
In Hungary, many people live with a high risk of meta-
bolic syndrome, which promotes the development of
atherosclerotic vascular diseases and type 2 diabetes
mellitus (T2DM) [5], mainly due to abdominal obesity.
The prevalence of the latter was 38% in males and 55%
in females [6] in 2014, and the morbidity of T2DM has
continuously been increasing [7]. Therefore, it is essen-
tial for heath professionals to be aware of the metabolic
risk of this population.
Body mass index (BMI) is widely used to monitor the
prevalence of obesity because the risk of coronary heart
disease, ischemic stroke, and T2DM rises in parallel with
the increase in the BMI [8]. Unfortunately, BMI provides
limited information about body fat content and no infor-
mation on central fat distribution, the degree of which
may be more closely related to metabolic risks than BMI
itself [9]. Body adiposity varies according to age and gen-
der, and BMI alone is not appropriate to distinguish
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between persons with excess body fat and persons with
high muscle mass, to whom the same metabolic risk
would be attributed based purely on their BMI [10].
Nonetheless, several reports suggest that the measure-
ment of waist circumference (WC) can compensate the
above described limitation of BMI since WC is more
closely related to visceral fat content, and thus to meta-
bolic risks. Previous research shows that on the one
hand, normal weight individuals with abdominal obesity
can have metabolic risk factors, and therefore being can-
didates for having elevated risk for metabolic syndrome
[11] or cardiovascular diseases (CVDs) [12], and on the
other hand, measurements of abdominal obesity, princi-
pally WC, are more closely related to metabolic risk
factors than the index of general adiposity [13]. Accord-
ing to Park et al. [10], WC as a marker of obesity is a
better predictor of coronary artery calcification than
BMI. Subjects with abdominal obesity were more likely
to have a metabolic syndrome compared to those with-
out abdominal obesity, therefore, WC should also be
measured and used in conjunction with BMI to assess
and predict metabolic risk, where possible, according to
the conclusion of a recent report of the World Health
Organization (WHO) [8].
There is, however, limited information about the use-
fulness of WC measurement in identifying cardiometa-
bolic risk factors in a large study sample. Therefore, in
our study, we aimed to examine whether non-obese sub-
jects with no chronic conditions but abdominal obesity
had a higher chance of having related metabolic risk fac-
tors, such as elevated blood pressure, high fasting blood
glucose, high cholesterol, high low-density lipoprotein
(LDL), low high-density lipoprotein (HDL), and high tri-
glyceride levels, compared to persons with no abdominal
obesity.
Materials and Methods
Study design and subjects
The programme, named ‘Public Health Focused Model
Programme for Organising Primary Care Services Backed
by a Virtual Care Service Centre’ (the Programme), has
been an innovative health promotion and public health pro-
ject, launched in July 2012 in Hungary in Swiss–Hungarian
cooperation. The aim of the Programme was to provide
efficient preventive services, contributing thereby to the
improvement of the general health status of the population,
and the reduction of social health inequality [14]. An elem-
ent of the new services developed by the programme was
the general practitioners’ cluster (GPC) model (described
elsewhere [15, 16]), which was designed to establish a
community-oriented screening system in Hungary with the
aim of providing comprehensive evaluation of the health
status of all adults above 18 years of age belonging to the
GPCs, irrespective of their health status. The health check
surveyed the sociodemographic status, lifestyle and health
attitude (nutrition, physical activity, alcohol use, smoking),
mental health, and history of chronic diseases and screen-
ings for cardiometabolic risk factors and hidden diseases.
The Health Status Assessment (HSA) was implemented by
a team of a trained nurse and a trained public health practi-
tioner [17], the task of who was to recruit the subjects, col-
lect questionnaire-based data, and perform the physical and
laboratory examinations.
It was a cross-sectional study conducted in adult per-
sons taking part in the Programme, living in the two vul-
nerable regions of Hungary (located in the North Eastern
part of the country). The target population comprised
32 655 adults, and the health data of 20 441 successfully
recruited adult persons were recorded between July 2012
and February 2016. First, subjects who had hypertension,
diabetes, ischemic heart disease, chronic obstructive pul-
monary disease (COPD), and/or cancer were excluded.
Then, further subjects were excluded because of the lack
of their BMI and/or WC data, the characteristics of these
12520 Hungarian adult subjects are shown in Additional
Table 1 (see Additional file 1). Finally, because of their
high BMI (≥25 kg/m2) scores, 7292 subjects were ex-
cluded. The final sample was formed by 5228 non-obese
individuals, who were divided into two groups according
to the WC. The two groups were formed based on the
definition and thresholds – WC >102 cm in men and WC
>88 cm in women – of Adult Treatment Panel III (ATP
III), which presents the National Cholesterol Education
Program’s (NCEP’s) updated recommendations for choles-
terol testing and management [18]. There were 4621 per-
sons in the group of normal WC (NWC), and 607 persons
in the group of high WC (HWC) (Fig 1).
Measurements
The HSA involved a health interview, physical examin-
ation (performed by a public health practitioner and a
community nurse), and laboratory tests. The data col-
lected and the questions applied in the HSA are shown
in Additional file 2 (see Additional file 2).
Based on the definition of metabolic syndrome [18],
laboratory data of blood glucose, total cholesterol, LDL
cholesterol, HDL cholesterol, and triglyceride levels were
Table 1 Normal ranges of laboratory parameters according to
ATP III/WHO
Laboratory parameters Normal Range Organization
Serum cholesterol < 5.2 mmol/L ATP III
Serum LDL cholesterol < 2.6 mmol/L ATP III
Serum HDL cholesterol ≥1.0 mmol/L ATP III
Serum triglyceride < 1.7 mmol/L ATP III
Fasting blood glucose level < 6.1 mmol/L WHO
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used. The thresholds for laboratory parameters given by
the ATP III or the WHO [19] are shown in Table 1.
The public health professionals followed the WHO
STEPS (STEPwise approach to surveillance) protocol to
measure the WC, that is, the measurement is made at
the approximate midpoint between the lowest rib and
the iliac crest [20]. BMI was defined as the body weight
divided by the square of the body height, and expressed
in units of kg/m2. Subjects with a BMI <25 kg/m2 were
classified as non-obese, whereas those with BMI ≥25 kg/
m2 were classified as obese according to the WHO defi-
nitions [21].
Blood pressure was measured by electronic blood pres-
sure monitor after a five-minute rest. The classification
of the American Heart Association, systolic blood pres-
sure ≥140 mmHg regarded as high blood pressure, was
applied [22].
Statistical analysis
A chi-square test was performed to show the basic
characteristics of the two groups. Pearson’s correlation
analysis was carried out to analyze the correlation be-
tween BMI and WC. A multiple logistic regression
model was used to define the association between the
metabolic risk factors and abdominal obesity with ad-
justments for age and gender. Metabolic risk factors
were used as dependent variables, and abdominal
obesity was defined as an independent variable. Odds
ratios (OR) and 95% confidence intervals (CI) are pre-
sented for high systolic blood pressure, high fasting
blood glucose, high total cholesterol, low HDL choles-
terol, high LDL cholesterol, and high triglyceride
levels. A p-value lower than 0.05 was considered sta-
tistically significant. Statistical analysis was performed
by using the SPSS 24.0 software.
Fig. 1 Schematic diagram of the study sample. BMI: body mass index, WC: waist circumference
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Results
The final sample involved 5228 non-obese subjects.
Out of them, 607 subjects (11.6%) had abdominal obes-
ity (HWC group), and there were 4621 subjects (88.4%)
with no abdominal obesity (NWC group) (Table 2).
Both groups involved more women than men, and the
majority of the patients were young (18–29 years) or
middle-aged (30–44 years) (Table 2).
Table 2 Characteristics of 5228 Hungarian adult subjects the data of who were recorded in the framework of the Swiss–Hungarian
Cooperation Programme (2012–2016)
Characteristics HWC group n (%) NWC group n (%) Total n (%)
WC 607 (11.6) 4621 (88.4) 5228 (100.0)
Gender***
Male 27 (4.4) 2055 (44.5) 2082 (39.8)
Female 580 (95.6) 2566 (55.5) 3146 (60.2)
Total 607 (100.0) 4621 (100.0) 5228 (100.0)
Age***
18–29 113 (18.6) 1852 (40.1) 1965 (37.6)
30–44 166 (27.3) 1463 (31.7) 1629 (31.2)
45–59 161 (26.5) 866 (18.7) 1027 (19.6)
60–74 111 (18.3) 323 (7.0) 434 (8.3)
≥ 75 56 (9.2) 117 (2.5) 173 (3.3)
Total 607 (100.0) 4621 (100.0) 5228 (100.0)
Systolic blood pressure***
Normal (< 140mmHg) 441 (74.2) 3884 (85.2) 4325 (83.9)
High (≥140mmHg) 153 (25.8) 675 (14.8) 828 (16.1)
Total 594 (100.0) 4559 (100.0) 5153 (100.0)
Fasting blood glucose**
Normal (< 6.1 mmol/L) 448 (91.2) 3361 (94.3) 3809 (93.9)
High (≥6.1 mmol/L) 43 (8.8) 205 (5.7) 248 (6.1)
Total 491 (100.0) 3566 (100.0) 4057 (100.0)
Total cholesterol***
Normal (< 5.2 mmol/L) 243 (50.3) 2184 (62.5) 2427 (61.0)
High (≥5.2 mmol/L) 240 (49.7) 1313 (37.5) 1553 (39.0)
Total 483 (100.0) 3497 (100.0) 3980 (100.0)
HDL cholesterol
Normal (≥1.0 mmol/L) 292 (95.4) 2356 (95.8) 2648 (95.7)
Low (< 1.0 mmol/L) 14 (4.6) 104 (4.2) 118 (4.3)
Total 306 (100.0) 2460 (100.0) 2766 (100.0)
LDL cholesterol
Normal (< 2.6 mmol/L) 70 (31.4) 616 (34.3) 686 (34.0)
High (≥2.6 mmol/L) 153 (68.6) 1181 (65.7) 1334 (66.0)
Total 223 (100.0) 1797 (100.0) 2020 (100.0)
Triglyceride**
Normal (< 1.7 mmol/L) 385 (80.2) 2966 (85.2) 3351 (84.6)
High (≥1.7 mmol/L) 95 (19.8) 514 (14.8) 609 (15.4)
Total 480 (100.0) 3480 (100.0) 3960 (100.0)
LDL: low-density lipoprotein; HDL: high-density lipoprotein
NWC: normal WC group with normal weight: WC ≤88 cm and BMI < 25 kg/m2 in females; and WC ≤102 cm and BMI < 25 kg/m2 in males
HWC: high WC group with normal weight: WC > 88 cm and BMI < 25 kg/m2 in females; and WC > 102 cm and BMI < 25 kg/m2 in males
BMI: body mass index; WC: waist circumference
**: p < 0.01; ***: p < 0.001 (Chi-square test of independence)
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Some further data in Table 2 demonstrate that a sig-
nificantly higher occurrence was found in the HWC
group vs the NWC group of high systolic blood pressure
(p<0.001), high fasting blood glucose (p=0.009), high
total cholesterol level (p<0.001), and high triglyceride
levels (p=0.004). The levels of HDL and LDL cholesterol
were not significantly different between the two groups.
The correlation analysis suggested that WC and BMI
had a significant correlation (p<0.001 both in males and
females). The Pearson’s correlation coefficients between
WC and BMI were 0.610 in males and 0.526 in females.
According to the results of the multiple logistic regres-
sion models, older people had significantly higher odds
for developing most of the metabolic risk factors. Sub-
jects in the age group of 30–44 years were significantly
more likely to have high systolic blood pressure, high
fasting blood glucose, high total cholesterol, and high
LDL cholesterol levels compared to the 18–29 year age
group (Table 3). This significantly increased risk of the
occurrence of the above mentioned metabolic risk fac-
tors was shown in the older age groups.
An increased risk for high triglyceride level was observed
in the 45–59 and 60–74 year old age groups compared to
the youngest age group. Subjects in the 45–59 and 60–74
year old age groups had significantly lower odds for low
HDL cholesterol. In contrast, the risk increased in the old-
est age group, although not significantly (Table 3).
Regarding gender, males had significantly higher odds
for having high systolic blood pressure, high fasting
blood glucose, low HDL cholesterol, and high triglycer-
ide levels (Table 3).
Subjects in the HWC group were more likely to have
some metabolic risk factors compared to those in the
NWC group. If a patient had abdominal obesity, the
odds for high systolic blood pressure, low HDL choles-
terol, and high triglyceride levels increased significantly
(Table 3). On the contrary, the risk for high LDL level
was lower in the HWC group compared to the NWC
group, but it was not significant. The odds of high total
cholesterol level was nearly the same in the NWC and
the HWC groups (Table 3).
Discussion
In this cross-sectional study, we examined the association
of abdominal obesity assessed by WC with the occurrence
of metabolic risk factors in non-obese subjects. 5228 sub-
jects were involved in our research, mostly young or
middle-aged, and more females than males. Our results
showed a high prevalence of abdominal obesity (11.6%)
among non-obese subjects. Our study also presented a
very high, positive correlation between BMI and WC,
which is consistent with other studies [23, 24].
Subjects with abdominal obesity were proved to have
significantly higher prevalence of high systolic blood
pressure, high fasting blood glucose, high total choles-
terol, and high triglyceride levels than subjects in the
NWC group.
Table 3 Odds ratios of metabolic risk factors in the Hungarian subjects with and with no abdominal obesity adjusted for age and
gender (multiple logistic regression models, data collected in the framework of the Programme between 2012 and 2016)
Characteristics High systolic
blood pressure
(≥140mmHg)
High fasting
blood glucose
(≥6.1 mmol/L)
High total
cholesterol
(> 5.2 mmol/L)
Low HDL
cholesterol
(< 1.0 mmol/L)
High LDL
cholesterol
(≥2.6 mmol/L)
High triglyceride
(≥1.7 mmol/L)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age (reference: 20–31)
30–44 2.01 (1.55–2.60)*** 2.36 (1.51–3.67)*** 2.93 (2.45–3.50)*** 0.94 (0.61–1.44) 2.98 (2.37–
3.75)***
1.20 (0.96–1.50)
45–59 7.28 (5.71–9.28)*** 5.01 (3.27–7.68)*** 7.35 (6.03–8.95)*** 0.53 (0.30–0.94)* 6.55 (4.89–
8.78)***
1.51 (1.18–
1.92)***
60–74 13.56 (10.24–
17.96)***
7.78 (4.88–12.41)*** 11.06 (8.43–
14.50)***
0.25 (0.08–0.80)* 5.44 (3.62–
8.18)***
1.78 (1.31–
2.42)***
≥ 75 22.21 (15.32–
32.21)***
10.22 (5.82–
17.94)***
6.08 (4.23–8.75)*** 1.17 (0.48–2.85) 5.37 (2.97–
9.73)***
1.40 (0.88–2.24)
Gender (reference:
females)
1.97 (1.65–2.35)*** 1.84 (1.38–2.45)*** 0.89 (0.77–1.03) 2.89 (1.90–
4.37)***
0.92 (0.75–1.13) 1.79 (1.45–
2.16)***
WC (reference: NWC
group)
1.53 (1.20–1.94)*** 1.37 (0.93–2.01) 1.02 (0.82–1.27) 2.06 (1.09–3.89)* 0.75 (0.54–1.05) 1.65 (1.27–
2.16)***
LDL Low-density lipoprotein; HDL High-density lipoprotein
NWC Normal WC group with normal weight: WC ≤88 cm and BMI < 25 kg/m2 in females; and WC ≤102 cm and BMI < 25 kg/m2 in males
WC: waist circumference; OR: odds ratio; CI: confidence interval
Odds ratios were calculated using multiple logistic regression models in which the dependent variable was defined as having metabolic risk factors and it was
adjusted for age and gender. The reference group was set as the females and the NWC group
*: p < 0.05; ***: p < 0.001
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The risk for having high systolic blood pressure, high
fasting blood glucose, high total cholesterol, and high
LDL cholesterol levels was age-dependent, these levels
were significantly higher in the age group of 30–44
years, and the risk was also significant in the older age
groups. In case of high triglyceride level, an increased
risk was found in the age groups 45–59 and 60–74 years.
In general, as individuals grow older, the body fat con-
tent increases, especially in the abdominal region, which
may be the cause of the elevated metabolic risk [25].
Therefore, screening of abdominal obesity is crucial in
the elderly. Furthermore, males were significantly more
affected by most of the cardiometabolic parameters,
hence it would be fundamental to measure WC particu-
larly in males. Likewise, the logistic regression model
indicated that patients with abdominal obesity had sig-
nificantly higher odds for high systolic blood pressure,
low HDL cholesterol, and high triglyceride levels.
Our results are in line with the findings of other re-
searchers [26, 27]. In the study of Okosun et al., WC is
positively associated with having two or more compo-
nents of the metabolic syndrome in three ethnic groups
in Americans [26]. According to the findings of Huang,
WC is a better predictor of insulin resistance [28] and a
better predictor of mortality [8] than BMI. Furthermore,
a strong association has also been documented between
abdominal obesity, CVDs, and total mortality [27].
It is well-known that obesity is strongly related to
metabolic, CV, and other diseases [29]. The health risks
of abdominal obesity have already been recognized as
well, although WC is still less commonly measured than
BMI in the clinical practice [8]. It is of importance that
some individuals with normal BMI are insulin resistant
and have metabolic abnormalities, which might contrib-
ute to an abnormal fat distribution, especially abdominal
obesity [30].
It is very important to measure body weight, height,
and WC in a professional and reliable way, for example,
during health examinations, as in self-reported health in-
terviews, the subjects tend to underestimate their weight
and/or overestimate body height [31].
Obviously, there are differences in the recommenda-
tions regarding the screening of obesity in the world.
The Obesity Society Guidelines (2013) for Managing
Overweight and Obesity in Adults do not recommend
measuring the WC [32]. The U.S. Preventive Services
Task Force (USPSTF) recommends the screening of all
adults for obesity by the calculation of the BMI, al-
though it also states that WC may be an acceptable
alternative to BMI measurement in some patient sub-
populations [33]. Nonetheless, Hungary has adapted the
available evidence that measurement of WC is effective
in the prevention of cardiometabolic disorders; thus, ac-
cording to a decree [34] regarding screenings done by
GPs and financed by the health insurance, measurement
of WC is to be included in the physical examination over
21 years of age, and it should be repeated every 5 years.
Despite the existing legal support for screenings in pri-
mary health care, the cardiometabolic preventive services
are used at much lower rates than recommended for the
age group of 21–64 years, and it might contribute to the
extremely high CV mortality in Hungary [35]. In a study
performed in a relatively large sample (3121 subjects),
cardiometabolic risk has been assessed in only 44.45% of
the individuals [36].
The logistic regression model also showed that the risk
for elevated LDL cholesterol level was lower in patients
with abdominal obesity. This is consistent with a study [37]
in which it was found that high LDL cholesterol remained
relatively unchanged with inreased WC. Possibly, the LDL
cholesterol level was modified by cholesterol-lowering ther-
apy, which primarily aims to decrease LDL cholesterol level
(it is one of the known limitations, see below).
Using the BMI alone to identify metabolic risks, sev-
eral patients with increased risk but normal BMI would
be missed. To measure WC is particularly important
above 30 years of age and in males, irrespective of their
BMI.
The strengths of our study were the large sample size,
the measurement of WC by trained health personnel,
and the interpretation of the results of a new, innovative
model programme in terms of screening in primary care
in Hungary.
Our limitations involve that the study was not repre-
sentative (selection bias), and we could not determine
cause-and-effect relationships due to the cross-sectional
type of this study.
Finally, not all laboratory parameters were available for
each subject. In this analysis, we applied the definition of
ATP III to classify the patient as having abdominal obes-
ity (but data were not analyzed according to Inter-
national Diabetes Federation (IDF) thresholds). As we
did not have information on which patients had choles-
terol lowering therapy, we could not exclude them from
the present analysis, although this therapy might modify
the measured LDL cholesterol levels and model calcula-
tions based on them.
Conclusions
Our results suggest that screening of abdominal obesity
by applying a simple, professionally performed measure-
ment of WC might be a suitable predictor of metabolic
syndrome, potentially more practical than, e.g., BMI.
The prevention of metabolic syndrome and the pos-
sible outcomes, such as CVDs and diabetes, would be es-
pecially beneficial in the Hungarian population, where
CVDs are the leading causes of death, and the morbidity
of T2DM is continuously increasing.
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